Finance

Lists
ALK-B:CPH
ALK-Abello A/S
DKK 241,80
-0,41%
(-1,00) 1D
26 Okt., 17:00:00 GMT+1  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for ALK-B...
Open
DKK 243,20
High
DKK 245,60
Low
DKK 241,20
Mkt. cap
49,18 mjd
Avg. vol.
238,36 k
Volume
145,68 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
Open
DKK 243,20
High
DKK 245,60
Low
DKK 241,20
Mkt. cap
49,18 mjd
Avg. vol.
238,36 k
Volume
145,68 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m
No. of employees
3 k
News stories
From web sources and news partners
The Globe and Mail
The Globe and Mail
·
10 minute gelede
American Analyst Updates: Oct 26th, 2026
Seeking Alpha
Seeking Alpha
·
11 minute gelede
3 things to look out for on Tuesday
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter J. Halling
Employees2,77 k
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitealk.net
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,53 mjd
1,73 mjd
1,77 mjd
1,80 mjd
Cost of goods sold
487,00 m
543,00 m
543,00 m
600,00 m
Cost of revenue
487,00 m
543,00 m
543,00 m
600,00 m
Research and development expenses
145,00 m
189,00 m
151,00 m
168,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
475,00 m
605,00 m
507,00 m
582,00 m
Operating expense
620,00 m
793,00 m
658,00 m
750,00 m
Total operating expenses
1,11 mjd
1,34 mjd
1,20 mjd
1,35 mjd
Operating income
423,00 m
397,00 m
570,00 m
445,00 m
Other non operating income
-
-
-
-
EBT including unusual items
419,00 m
393,00 m
583,00 m
452,00 m
EBT excluding unusual items
419,00 m
403,00 m
583,00 m
452,00 m
Income tax expense
105,00 m
127,00 m
146,00 m
113,00 m
Effective tax rate
25,06%
32,32%
25,04%
25,00%
Other operating expenses
-
-1,00 m
-
-
Net income
314,00 m
266,00 m
437,00 m
339,00 m
Net profit margin
20,52%
15,35%
24,68%
18,89%
Earnings per share
1,40
1,20
2,00
1,50
Interest and investment income
-
28,00 m
13,00 m
7,00 m
Interest expense
-4,00 m
-6,00 m
-
-
Net interest expenses
-4,00 m
22,00 m
13,00 m
7,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
510,00 m
400,00 m
654,00 m
531,00 m
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google-programme